OTC : BTTX

Better Therapeutics, Inc. — Earnings Estimates

$0.0001 USD

$0 (0.0%)

Volume
3K
Average Volume
4.11K
Market Capitalization
$5.45K
P/E Ratio
0.00
Dividend Yield
0.00%
Price Target
Year High
$0.00
Year Low
$0.00
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$1.37

Annual earnings financials

BTTX financial data with annual/quarterly toggle

BTTX GAAP EPS - Annual & Quarterly

BTTX Sales Revenue - Annual & Quarterly

BTTX Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

BTTX Estimated and Actual Revenue by Quarter
BTTX Estimated and Actual EPS by Quarter
BTTX Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2026-12-30 1 - - - - - -
2026-09-30 1 - - - - - -
2026-06-30 1 - - - - - -
2026-03-30 1 - - - - - -
2025-12-30 1 - - - - - -
2025-09-30 1 - - - - - -
BTTX Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2026-12-30 1 -5.77M -5.77M -5.77M 1.19B 1.19B 1.19B
2026-09-30 1 -6.93M -6.93M -6.93M 985.48M 985.48M 985.48M
2026-06-30 1 -8.08M -8.08M -8.08M 790.4M 790.4M 790.4M
2026-03-30 1 -8.47M -8.47M -8.47M 605.77M 605.77M 605.77M
2025-12-30 1 -10.39M -10.39M -10.39M 172.25M 172.25M 172.25M
2025-09-30 1 -10.39M -10.39M -10.39M 144.63M 144.63M 144.63M
BTTX Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2026-12-30 1 9.92M 9.92M 9.92M 1 -0.15 -0.15 -0.15
2026-09-30 1 8.2M 8.2M 8.2M 1 -0.18 -0.18 -0.18
2026-06-30 1 6.58M 6.58M 6.58M 1 -0.21 -0.21 -0.21
2026-03-30 1 5.04M 5.04M 5.04M 1 -0.22 -0.22 -0.22
2025-12-30 1 1.43M 1.43M 1.43M 1 -0.27 -0.27 -0.27
2025-09-30 1 1.2M 1.2M 1.2M 1 -0.27 -0.27 -0.27